跳至主要内容
临床试验/NCT00724204
NCT00724204已完成1 期

Functional Evaluation of a Follow on Formula Supplemented With Lactobacillus Salivarius CECT5713

Puleva Biotech2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2006年4月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
80
试验地点
2
主要终点
Adverse reactions

研究概览

简要总结

The aim of the trial is to evaluate safety of a follow on formula supplemented with Lactobacillus salivarius CECT5713. A randomized double blind placebo controlled trial was carried out. Eighty six months old children were recruited by the department of pediatrics of Hospital Univeristario San Cecilio. Children were divided in two groups that consumed a follow on formula supplemented or not with the probiotic strain during 6 months. Fecal samples were obtained at the recruitment, at 3 months and at the end of the trial. In addition revision by the pediatrician was performed once a month and possible adverse effects were recorded both by the pediatrician and by parents.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
6 Months 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Healthy six months old children

排除标准

  • Lactose intolerance
  • Cow's milk protein allergy
  • Serious metabolic diseases
  • Antibiotic treatment
  • Serious gastrointestinal diseases

结局指标

主要结局

Adverse reactions

时间窗: 3 months and 6 months

次要结局

  • growth parameters (height, length, head circumference)(3 months and 6 months)
  • Fecal microbiota(3 months and 6 months)
  • Fecal short chain fatty acids(3 months and 6 months)

研究者

发起方
Puleva Biotech
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验